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Abstract
The mammalian biological clock, located in the hypothalamic suprachiasmatic nuclei (SCN), imposes its temporal structure
on the organism via neural and endocrine outputs. To further investigate SCN control of the autonomic nervous system we
focused in the present study on the daily rhythm in plasma glucose concentrations. The hypothalamic paraventricular
nucleus (PVN) is an important target area of biological clock output and harbors the pre-autonomic neurons that control
peripheral sympathetic and parasympathetic activity. Using local administration of GABA and glutamate receptor
(ant)agonists in the PVN at different times of the light/dark-cycle we investigated whether daily changes in the activity of
autonomic nervous system contribute to the control of plasma glucose and plasma insulin concentrations. Activation of
neuronal activity in the PVN of non-feeding animals, either by administering a glutamatergic agonist or a GABAergic
antagonist, induced hyperglycemia. The effect of the GABA-antagonist was time dependent, causing increased plasma
glucose concentrations only when administered during the light period. The absence of a hyperglycemic effect of the
GABA-antagonist in SCN-ablated animals provided further evidence for a daily change in GABAergic input from the SCN to
the PVN. On the other hand, feeding-induced plasma glucose and insulin responses were suppressed by inhibition of PVN
neuronal activity only during the dark period. These results indicate that the pre-autonomic neurons in the PVN are
controlled by an interplay of inhibitory and excitatory inputs. Liver-dedicated sympathetic pre-autonomic neurons
(responsible for hepatic glucose production) and pancreas-dedicated pre-autonomic parasympathetic neurons (responsible
for insulin release) are controlled by inhibitory GABAergic contacts that are mainly active during the light period. Both
sympathetic and parasympathetic pre-autonomic PVN neurons also receive excitatory inputs, either from the biological
clock (sympathetic pre-autonomic neurons) or from non-clock areas (para-sympathetic pre-autonomic neurons), but the
timing information is mainly provided by the GABAergic outputs of the biological clock.
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Introduction
The role of the CNS in glucoregulation has been recognized
since the classical experiments of Bernard in 1849 [1]. The
hypothalamus is considered the crucial CNS region involved in
glucose metabolism, using a rich innervation of the liver by
sympathetic and parasympathetic nerves to regulate glucose
metabolism in a reciprocal manner [2–4]. The hypothalamus also
harbors the endogenous or biological clock in the suprachiasmatic
nuclei (SCN) [5–7]. The biological clock imposes a temporal
structure on the brain and peripheral organs via both neural and
endocrine outputs [8,9]. Previously, we proposed that the
biological clock generates the daily rhythm in plasma melatonin
concentrations via the combination of a continuous (glutamatergic)
stimulation of the pre-autonomic neurons in the paraventricular
nucleus of the hypothalamus (PVN) that are at the origin of the
sympathetic innervation of the pineal, and a nocturnal withdrawal
of the inhibitory (GABA-ergic) SCN inputs to these neurons
[10,11]. To further investigate SCN control of autonomic nervous
activity we focused in the present study on the daily rhythm in
plasma glucose concentrations, especially in view of the recently
demonstrated rhythmic control of glucose metabolism in the liver
[12–15] and the clear involvement of the sympathetic and
parasympathetic input to the liver in glucose metabolism. Indeed
a daily rhythm in plasma glucose concentrations, with peak levels
attained at the end of the sleep period, has been shown previously
[16]. Data obtained from both human and rat studies strongly
suggest that the rise in plasma glucose concentrations at the end of
the sleep period is endogenous and primarily caused by an
increased hepatic glucose production (HGP) controlled by the
endogenous clock located in the central nervous system [17–20].
Moreover, we recently found that local administration of the
GABA-A receptor antagonist bicucilline (BIC) or the glutamate
receptor agonist NMDA in the PVN caused pronounced
hyperglycemia. In both conditions this hyperglycemic effect of
PVN stimulation could be prevented by a selective denervation of
the sympathetic autonomic input to the liver [21]. By combining
the ICV administration of BIC with a euglycemic clamp Lang et al
[22] clearly showed that the BIC induced hyperglycemia is due to
an increased HGP.
PLoS ONE | www.plosone.org 1 September 2008 | Volume 3 | Issue 9 | e3194To investigate possible daily changes in the activation of the pre-
autonomic PVN neurons, we first compared the hyperglycemic
response evoked by GABAergic and glutamatergic (ant)agonists
when administered into the PVN at different moments of the L/D-
cycle. Secondly we studied the effect of an SCN-lesion, i.e.,
removal of the proposed GABAergic projection, on the hypergly-
cemic effect of BIC applied in the PVN. Thirdly, we inhibited
neuronal activity in the PVN during a scheduled meal at different
times of the light/dark-cycle in order to investigate whether the
parasympathetic input to the pancreas, too, is dependent on (daily
changes in) PVN neuronal activity. The results are synthesized
into a model explaining how the biological clock is able to
somatotopically enforce differentiated autonomic rhythms onto
different body compartments.
Results
A total of 280 Wistar rats were used in this study. Histological
analysis of probe placement showed that in the majority of the
animals, the tip of the microdialysis probes was consistently
positioned within 50–100 mm of the borders of the PVN. Typical
examples of probe placements can be found in our previous papers
[11,23]. Approximately 20% of the data had to be discarded
because of incorrect probe placements, a blockade of the
microdialysis probes, a blockade of the jugular catheter, non-
sufficient recovery of the animal from the operation, or an
incomplete data set.
Experiment 1: Time dependent effects of daily changes in
GABAergic and glutamatergic PVN inputs on basal
plasma glucose and insulin concentrations
In order to investigate possible daily changes in the activity of
GABA- and/or glutamate-containing projections to the PVN we
used muscimol (MUS) and NMDA to activate and bicucilline
(BIC) and MK801 to antagonize GABAergic and glutamatergic
receptors, respectively, and circulating plasma glucose and plasma
insulin as the main readout. Mean basal plasma glucose and
plasma insulin concentrations at the start of the different
experiments, as well as a statistical analysis of their response are
indicated in Tables S1 and S2.
Only BIC administration showed a strong time-of-day
dependency when comparing for all 8 experiments (i.e. BIC,
MUS, NMDA and MK801 at either ZT5 or ZT15) the day of
drug administration with the control day 1 week later (Fig. 1),
i.e., ANOVA showed a significant effect of Treatment during the
ZT5, but not the ZT15, experiment. For the other drugs
either no significant effect of Treatment was found, or, as for
NMDA, a significant effect of Treatment was found at both ZT5
and ZT15.
Plasma insulin concentrations were only significantly affected
by the ZT15 NMDA and MUS administration (Fig. 2). NMDA
administration in the PVN area caused a small increase of
plasma insulin concentrations as compared to the control day
(p=0.015 and p=0.012, effects of Treatment and Interaction,
respectively), whereas administration of MUS caused a signifi-
cant decrease of plasma insulin concentrations. Basal plasma
insulin at ZT15 were significantly lower than those at ZT5,
probably due to the 2-h fast at the beginning of the dark period.
In conclusion, the time dependency of the BIC-induced
hyperglycemia indicates a daily change in GABAergic input to
the PVN, with higher levels of GABAergic input during the light
period. Especially, since the hyperglycemic effect of NMDA
administration in the PVN was present during both the ZT5 and
ZT15 experiment it is most probable that the time-dependency
of the BIC-induced hyperglycemia is due to a daily rhythm in
the activity of the GABAergic inputs to the PVN, instead of
daily changes in the pathway downstream from the PVN. Basal
plasma insulin levels (i.e. during non-feeding conditions) only
respond to changes in PVN neuronal activity during the dark
period.
Experiment 2 : Origin of the daily change in GABAergic
input to the PVN
In order to investigate whether the daily change in GABAergic
input to the PVN is derived from the biological clock located in the
SCN we repeated the PVN administration of BIC in groups of
SCN-lesioned and SHAM-lesioned animals. By measuring their
diurnal water intake pattern 11 of the 36 animals originally
operated upon were identified as having an effective SCN lesion
and selected for further experiments. Of the 11 SCN-lesioned and
11 SHAM animals equipped with bilateral PVN probes and a
jugular vein catheter, 10 SCN-lesioned animals and 9 SHAM
operated animals completed the BIC administration experiment.
Eight animals in both groups also completed the control
experiment 1 week later. Histological stainings using vasopressin
(VP) and vasoactive intestinal polypeptide (VIP) immunocyto-
chemistry were used to check for remaining pieces of SCN tissue at
the border of the lesion after finishing the physiological
experiments, but in all 10 cases could confirm the completeness
of the lesion. Typical examples of such a lesion and the histological
stainings can be found in our previous papers [10,16,24–27]. In
agreement with the findings in Experiment-1, BIC caused a
significant hyperglycemia in the SHAM-lesioned animals, but in
SCN-lesioned animals glucose responses during BIC administra-
tion did not differ from those on the control day (Fig. 3). Due to
the large variability in the glucose responses of the BIC treated
SCN-lesioned animals the effect of Lesion (i.e. BIC in SCN-lesioned
versus BIC in SCN-sham animals) did not reach significance
(p=0.122), but the AUC for the glucose response to BIC was
significantly smaller in the SCN-lesioned animals than that in the
SHAM-lesioned animals (p=0.041). In conclusion, ablation of the
suprachiasmatic nuclei removes (or silences) the majority of the
GABAergic inputs to the PVN that are responsible for the
hyperglycemia induced by the PVN administration of the GABA-
antagonist BIC.
Experiment 3 : Daily changes in PVN neuronal activity
and its effects on feeding-induced insulin responses
Basal plasma glucose and hormone concentrations, i.e. just
before opening the door in front of the food hopper and the start
of the meal, are indicated in Table S3. PVN administration of
MUS during feeding at ZT8 did not significantly affect the glucose
and insulin responses, despite the somewhat smaller mean insulin
increments during the experimental session (Fig. 4). On the other
hand, enhancing GABAergic activity in the PVN during the ZT14
meal caused a significant decrease of the feeding-induced glucose
response, as well as the insulin response (Table S4). Administration
of the cocktail of NMDA antagonists in the PVN during the ZT8
meal did not significantly attenuate the glucose response, or the
insulin response (Table S4). On the other hand, blockade of the
NMDA receptors in the PVN during the ZT14 meal caused a
significant decrement of both the glucose and insulin response
(Table S4). In conclusion, PVN neuronal activity during the ZT14
meal (i.e. in the dark period), but not the ZT8 meal (i.e. during the
light period), is necessary to elicit a complete glucose and insulin
response.
Diurnality of Plasma Glucose
PLoS ONE | www.plosone.org 2 September 2008 | Volume 3 | Issue 9 | e3194Figure 1. Changes in plasma glucose concentrations during a 2-h administration of NMDA, the NMDA antagonist MK801,
Bicuculline, or Muscimol in the PVN at either ZT5 (left column) or ZT15 (right column). Filled symbols indicate the effect of the drug,
whereas open symbols show the results of the control experiment in the same animals one week later. Only 3 out of the 8 different treatment
protocols showed a significant effect of drug treatment, i.e. NMDA at ZT5 (p=0.008) and at ZT15 (p=0.009), and the Bicuculline treatment at ZT5
(p=0.002).
doi:10.1371/journal.pone.0003194.g001
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Glutamate and GABA are the most abundant excitatory and
inhibitory neurotransmitters in the central nervous system. The
present study shows a pronounced time-of-day dependent hyper-
glycemic effect of the GABA-antagonist bicuculline, but not the
glutamate receptor agonist NMDA, when administered in the
paraventricular nucleus of the hypothalamus (PVN). Results in
SCN-lesioned animals clearly show that this time dependency is
derived from the biological clock situated in the hypothalamic
suprachiasmatic nuclei (SCN). Combined with our previous liver-
denervation experiments [23], the present results reveal a control
mechanism for the daily rhythm in plasma glucose concentrations
that very much resembles the one described earlier for the daily
rhythm in plasma melatonin concentrations [11]. The SCN uses a
continuously active glutamatergic projection and a rhythmically
active GABAergic projection to control the activity of the
sympathetic pre-autonomic neurons in the PVN. The scheduled
feeding experiments provide the first evidence that also the
parasympathetic pre-autonomic neurons in the PVN are under the
controlofarhythmicGABAergicinput.Contrarytothesympathetic
pre-autonomic neurons, however, activation of the parasympathetic
pre-autonomic neurons does not depend on afferent glutamatergic
inputs from the SCN.
An alternative explanation for the strong time-of-day depen-
dency of the hyperglycemic effect of BIC could be the well-known
rhythm in hepatic glycogen stores with its acrophase at light onset
[28–30]. Moreover, recent gene expression studies have revealed
Figure 2. Changes in plasma insulin concentrations during a 2-h administration of NMDA or Muscimol in the PVN at ZT15. Filled
symbols indicate the effect of the drug, whereas open symbols show the results of the control experiment in the same animals one week later.
doi:10.1371/journal.pone.0003194.g002
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expression pattern, even during fasting conditions, including the
well known core clock genes as well as those encoding several key
enzymes involved in glucose metabolism [12–15]. Since the trough
in hepatic glycogen stores coincides in time with the reduced
hyperglycemic response to BIC (i.e. at ZT15) [31–33], we
investigated whether a (almost) complete absence of hepatic
glycogen stores (induced by 2 nights of food deprivation) would
result in a decreased hyperglycemic effect of BIC. The results of
the food-deprivation experiment were very clear. Although food-
deprivation caused a much more profound reduction of hepatic
glycogen stores than the daily light/dark-cycle (i.e. .90% versus
630%,respectively), ithadnoeffectwhatsoever on the BIC-induced
hyperglycemia (Fig. S1). The first evidence for an involvement of the
suprachiasmatic nuclei in the hyperglycemic effect of BIC
administered in the PVN was given in our previous study [23],
when we showed that the administration of TTX in the SCN and
DMH, but not in the PVN or VMH, caused an increase of plasma
glucose concentrations. This mimicry of the hyperglycemic effect of
BIC by silencing the SCN or DMH indicated that part of the
GABAergic input to the PVN might be derived from the SCN and
DMH. The present study adds two more pieces of evidence for the
involvement of the SCN. Next to the time-of-day dependency of the
BIC-induced hyperglycemia, the absence of a BIC-induced
hyperglycemic effect in the SCN-lesioned animals provides a strong
indication that a major part of the GABAergic input to the PVN (at
least the part that is responsible for the BIC-induced hyperglycemia)
is under control of the SCN. This could be either direct projections
from GABAergic SCN neurons to the PVN or GABAergic
projections to the PVN derived from SCN target areas. In the
intact animal these afferent GABAergic inputs to the PVN from, for
instance the subPVN and DMH, would be activated by the SCN
during the light period. SCN lesions result in a ‘‘silencing’’ of these
intermediate GABAergic neurons and, subsequently, in a lack of
effect of BIC in the PVN. The present results thus clearly indicate
that a major part of the GABAergic input to the PVN is under
(in)direct control of the SCN-a situation which is clearly different
from the GABAergic afferents to the PVN that are in control of the
HPA-axis, as an SCN-lesion does not remove the stimulatory effect
of BIC on the release of corticosterone [25] and Fig. S2.
Recently Bando et al [34] demonstrated that the parasympa-
thetic part of the autonomic nervous system, too, is under a
rhythmic control of the SCN. However, our previous study [23],
as well as the first set of experiments in the present study, provided
little evidence for a hypothalamic control of the parasympathetic
pre-autonomic neurons in the PVN. None of the drugs produced a
clear hypoglycemia as would be expected with an activation of the
parasympathetic input to the liver [35,36]. Profound changes in
plasma insulin concentrations were not observed either, suggesting
that clear effects on the parasympathetic system might only be
detected when the system is stimulated. Indeed, whereas a daily
rhythm in basal plasma insulin concentrations is small or non-
existent [16,37,38], a pronounced daily modulation of the feeding-
induced insulin responses has been described several times [39–
41]. Therefore, we decided to investigate whether a modulation of
the neuronal activity in the PVN during feeding would reveal
clearer effects on the parasympathetic system (i.e. insulin release).
The results of these experiments show that 635% of the feeding-
induced insulin response during the dark period is dependent on
an activation of PVN neurons. Since the magnitude of the MUS
and NMDA-antagonist effects was quite comparable, the main
force for the activation of PVN neurons seems to be a
glutamatergic input. On the other hand, the feeding-induced
insulin response at ZT8 is not dependent upon neuronal activity in
the PVN, since neither MUS nor the cocktail of NMDA-
antagonists significantly changed the amount of insulin released.
Figure 3. Changes in plasma glucose concentrations during a 2-h administration of Bicuculline in the PVN of SCN-lesioned (closed
triangles) and sham-lesioned animals (closed circles). Open symbols show the results of the control experiment in the same animals one week
later. Ablation of the SCN caused a profound reduction of the Bicuculline induced hyperglycemia, i.e. there was no significant difference between the
Bicuculline treatment and the control day (Treatment, p=0.647; Sample6Treatment, p=0.121), contrary to the clear Bicuculline effect in the sham-
lesioned animals (Treatment, p=0.013; Sample6Treatment, p=0.001). Basal plasma glucose concentrations (at t=0) did not differ between SHAM-
lesioned and SCN-lesioned animals (SCN-Sham: 6.660.2 and 6.860.3, and SCN-Lesion: 6.760.2 and 6.560.1 mmol/l for experimental and control
days, respectively).
doi:10.1371/journal.pone.0003194.g003
Diurnality of Plasma Glucose
PLoS ONE | www.plosone.org 5 September 2008 | Volume 3 | Issue 9 | e3194Figure 4. Changes in plasma glucose and plasma insulin concentrations during a scheduled meal at either ZT8 or ZT14 and the
concurrent administration of Muscimol or a cocktail of NMDA-antagonists in the PVN (closed circles). Open circles show the results of
the control experiment in the same animals one week later. Meal feeding caused significant increases of plasma glucose and plasma insulin
concentrations on all occasions. Both Muscimol and treatment with the NMDA-antagonist cocktail caused a significant reduction of the glucose and
insulin response during the ZT14, but not the ZT8, meal. These changes in glucose and insulin responses were observed despite matching of meal
size during drug treatment and control meals. For details of statistical analysis see Tables S6 and S7.
doi:10.1371/journal.pone.0003194.g004
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with either MUS or NMDA-antagonists, also caused a 665%
reduction of the glucose response. Since the reduced glucose
responses cannot be explained by smaller insulin responses, the
inhibitory effects of MUS and the NMDA-antagonists on the
plasma glucose responses indicate an increased nocturnal
parasympathetic input-in this case an increased parasympathetic
input to the gastro-intestinal tract that will shorten the transit time
of food from the stomach to the intestines and will increase the
absorption rate of glucose from the intestines. Indeed, both
parameters also show a clear circadian rhythm mediated by the
vagal innervation [42,43].
At present it is not clear where the glutamatergic input to the
parasympathetic pre-autonomic PVN neurons originates, al-
though the diurnal variation clearly indicates an involvement of
the SCN. Strubbe et al [39] found increased glucose and insulin
responses during daytime meals in SCN-lesioned animals, i.e.
similar to the night time values in control animals. Similar data
were provided by Yamamoto et al [40] after an oral glucose load.
It was concluded that ablation of the SCN removes an inhibitory
factor during the light period, and suggested that in the intact
animal the SCN exerts an inhibitory effect on parasympathetic
activity during the light period. Remarkably, Strubbe et al [39]
also showed that prior treatment with atropine reduced the
nighttime insulin and glucose responses to daytime values but
hardly affected the daytime responses, i.e. very much similar to our
MUS or NMDA-antagonist treatments. Could it be that like the
sympathetic pre-autonomic neurons, the parasympathetic pre-
autonomic neurons are also inhibited by a GABAergic input from
the SCN during the daytime? Unfortunately we were unable to
reveal such an inhibitory effect of GABA on the parasympathetic
pre-autonomic neurons with BIC administration in the PVN, due
to its strong activation of the sympathetic pre-autonomic neurons.
The increased sympathetic input to the pancreas not only inhibits
the release of insulin, but its strong hyperglycemic effect also
obscures a possible hypoglycemic effect of an increased parasym-
pathetic activity. On the other hand, the increased daytime
glucose and insulin responses in the SCN-lesioned animals as
described above indicate that the glutamatergic input to the
parasympathetic pre-autonomic neurons is not coming from the
SCN. Csaki et al. [44] showed that the PVN receives a vast
amount of glutamatergic afferents, arising from a number of
hypothalamic nuclei including the VMH and the arcuate nucleus
[45]. Indeed electrical stimulation of the VMH increases
glycogenolysis and glucose output from the liver mainly via the
hepatic nerves [46]. More recently Tong et al [47] very nicely
demonstrated that glutamate release from VMH neurons is
necessary to prevent hypoglycemia (i.e. glutamate release from
VMH neurons promotes glucose production). However, the direct
projection from the VMH to the PVN appears to be rather sparse,
whereas on the other hand massive projections have been
described to the DMH and subPVN [48,49]. Therefore, most of
the VMH input to the pre-autonomic PVN neurons might be
indirect through interneurons in the DMH and subPVN. Indeed,
such an intermediate role for the DMH and subPVN was also
proposed with regard to the SCN–PVN connection [50,51]. We
suggest that the (in)direct glutamatergic projections to the
parasympathetic pre-autonomic neurons are activated, irrespective
of the time-of-day, by viscerosensory stimuli propagated to the
VMH via the nucleus of the solitary tract and parabrachial nucleus
[52,53] or by blood-borne signals acting through the arcuate
nucleus [54]. The daily rhythm in parasympathetic PVN output
then results from the rhythmic input of GABAergic SCN afferents
(Fig. 5). Indeed, Decavel & VandenPol [55] showed a widespread
convergence of GABAergic and glutamatergic afferents on PVN
neurons.
Figure 5. Schematic presentation of the daily activity pattern of hypothalamic populations of GABAergic and glutamatergic
neurons implicated in the autonomic control of the daily rhythms in hepatic glucose production (left figure) and feeding-induced
insulin release (right figure).
doi:10.1371/journal.pone.0003194.g005
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drugs to neighboring areas is always an important concern for the
present type of studies. By comparing drug effects of the same drug
applied in different hypothalamic nuclei we could calculate in a
previous study that when applied by microdialysis the effective
spread of BIC was ,0.5 mm [23]. Thus, clearly with the current
technique we are not able to differentiate between drug effects on
the PVN proper and the subPVN. Therefore we cannot exclude
that (some of) the effects involve indirect effects via intermediate
neurons in the subPVN instead of direct projections to the pre-
autonomic neurons. In fact, we recently found clear evidence for
such a mechanism [56], albeit thus far only for the neuroendocrine
PVN neurons. Our experiments were performed under L/D
conditions thus it could be argued that the apparent temporal
differences might be due to non-specific effects of light rather than
a particular action of the SCN. Indeed, direct retinal projections to
hypothalamic nuclei other than the SCN, including the (sub)PVN,
have been demonstrated, be it to a much smaller extend [57,58].
However, the results of the SCN lesion animals clearly show that a
major part of the temporal difference in the hyperglycemic
response to BIC is derived from SCN projections. As the temporal
differences in the feeding-induced insulin response were also
abolished by SCN removal [39], it seems very unlikely that the
current results can be explained by non-specific effects of light.
The SCN lesion experiments also exclude that the presently found
temporal differences are due to diurnal differences in feeding
behavior and/or locomotor activity. Moreover, the animals were
either not eating during the experiment or fed a similar sized meal.
Next to the autonomic nervous system also circulating
epinephrine, glucagon and corticosterone are major players in
the regulation of plasma glucose [59,60]. Moreover, GABA
antagonism in the PVN also results in robust increases in plasma
epinephrine [61,62], as well as glucagon and corticosterone [23].
However, our denervation studies clearly show that these
hormonal changes cannot be the sole explanation for the changes
in hepatic glucose production observed after the hypothalamic
infusions [23,63]. Also in the current study there was no
correlation between the drug-induced changes in plasma glucose
(Fig. 2) and plasma corticosterone (Fig. S3).
With regard to the circadian control of the autonomic nervous
system the picture that emerges from the present data and our
previous experiments is one that shows an important role for a
GABAergic-glutamatergic switch, not only with respect to the
sympathetic branch but also where it concerns the parasympa-
thetic branch. The different timing of the daily peak in melatonin
release (i.e. ZT16–22) and hepatic glucose production (i.e. ZT10–
14) indicates that the GABAergic efferents from the SCN
differentiate between the pre-autonomic neurons that control the
sympathetic input to the pineal and the neurons that control the
sympathetic input to the liver. In view of this highly differentiated
somatotopic organization it is not surprising that SCN efferents are
also able to differentiate between sympathetic and parasympa-
thetic pre-autonomic neurons. Indeed, using a combination of
double retrograde viral tracing and selective organ denervation,
we found neuro-anatomical evidence for a somatotopic organiza-
tion in the SCN [64], as well as for the maintenance of a
segregation of sympathetic and parasympathetic neurons up to the
level of the SCN [65].
In conclusion, the daily rhythm in the activity of the pre-
autonomic neurons is predominantly determined by somatotopically
organized GABAergic SCN outputs that inhibit selective groups of
pre-autonomic neurons at specific times of the L/D-cycle. The
abundant presence of GABAergic neurons in the SCN nicely fits
with such a prominent role for GABAergic SCN efferents [66,67].
On the other hand, only a minor part of the rhythmic activity in pre-
autonomic neurons seems to depend on glutamatergic efferents from
the SCN. Finally, the prominent circadian rhythmicity of a number
of peptidergic SCN transmitters [68,69] and the consistent co-
localization of small fast-acting transmitters such a GABA and
glutamate with hypothalamic peptides [70], also within the SCN
[67,71],suggestsanimportant modulatoryrolefor theSCN peptides
on its final output, despite the pronounced GABAergic and
glutamatergic effects described above.
Materials and Methods
Animals
Male Wistar rats (Harlan, The Netherlands) were housed at a
room temperature of 2161 C with a 12-h light/dark (L/D) cycle
(lights on at 07.00 h). For experiments performed during the dark
period, animals were housed in a reversed L/D-cycle with lights
on at 19.00 h. Animals were allowed to adapt to the new
environment for 2 weeks (or 6 weeks in case of housing in a
reversed L/D-cycle) before the first experiments. Animals were
kept with 4–6 animals per cage until one week before surgery, at
which time they were transferred to individual cages
(25625635 cm). Food and water were available ad libitum, except
during experimental sessions, when only water was available.
Animals weighed between 300–350 g at the time of experiments.
Rats were anaesthetized using a mixture of Hypnorm (0.05 ml/
100 g body weight, i.m.) and Dormicum (0.04 ml/100 g body
weight, s.c.). All of the following experiments were conducted
under the approval of the Animal Care Committee of the Royal
Netherlands Academy of Arts and Sciences.
Surgical procedures
Jugular venectomy and intracerebral microdialysis
probes. Experimental animals destined to undergo infusion and
blood sampling studies were fitted with bilateral microdialysis probes
and an intra-atrial silicone catheter through the right jugular vein
when the body weight had reached 300 g, as described previously
[23].Aftersurgery,ratswereallowedtorecoverforatleast10daysto
allow complete reinstatement of circadian rhythms [72]. During
experiments, the animals were permanently connected to the blood-
sampling and microdialysis lines, as described previously [23]. The
microdialysis probes were stereotaxicallyimplanteddirectlylateralto
the PVN (stereotaxic coordinates with flat skull: 1.8 mm posterior to
bregma, 2.0 lateral from the midline, 7.9 mm below the brain
surface, and 10u angled to the sagittal plane).
SCN-lesions. A total of 36 rats (180–200 g) were operated
upon in order to ensure a sufficient number of effectively lesioned
animals. For the SCN lesion procedure animals were mounted
with their heads in a David Kopf stereotact (Tujunga, CA) with
the toothbar set at +5.0 mm, and sustained a bilateral lesion of
their SCN (coordinates 1.4 mm rostral to bregma, 1.1 mm lateral
to the midline and 8.3 mm below the brain surface) using bilateral
lesion electrodes, 0.2 mm in diameter, that were heated to 85uC
for 1 minute (lesion generator, Radionics, Burlington, MA). This
temperature/duration combination was found empirically to result
in lesion large enough to eliminate the SCN, but small enough to
leave surrounding hypothalamic structures, such as the PVN and
supraoptic nucleus, intact. Drawback of minimizing the lesion size,
however, is the limited yield of completely lesioned animals
(,30%). In order to restrict the number of (false positive) animals
to be operated upon an initial screening is made by measuring
their diurnal water intake. After a 2-week recovery period the
effectiveness of the SCN-lesions was checked by measuring the
animals’ drinking behavior during a 3-week period [10,27]. By this
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SHAM-lesioned animals were treated in exactly the same way as
the SCN-lesioned animals, except for the fact that the lesion
electrodes were not heated. In the 6
th week after the operation
groups of effectively SCN-lesioned animals and SHAM-lesioned
animals were operated upon as described above.
Physiological experiments. Ringer’s perfusion (3 ml/min)
was started 2 hours before the start of the 2-h drug infusion period
and lasted for 2 more h after the change back to Ringer=s. The 2-
h drug infusion periods were initiated at ZT5 or ZT15. Blood
samples (0.6 ml) were taken 30 min before (t=230) and 0, 30, 60,
120 and 180 min after the start of the drug infusion. The following
neurotransmitter (ant)agonists were administered to the PVN:
muscimol (MUS; a potent GABAA receptor agonist; 100 mM),
bicucilline (BIC; a GABAA receptor antagonist; 100 mM), NMDA
(a glutamate receptor agonist; 100 mM), and MK801 (a potent,
selective and non-competitive NMDA receptor antagonist;
100 mM). In the scheduled feeding experiments (see below) a
cocktail of NMDA antagonists was used. This cocktail consisted of
MK801 (100 mM), AP5 (500 mM), and DNQX (100 mM). All drug
concentrations were chosen on basis of our own previous
microdialysis experiments (BIC, MUS, NMDA and MK801
[10,23] or other studies employing reverse microdialysis to
administer these drugs (AP5 [73] and DNQX [74]). In principle
1 week later all animals participated in a 2
nd session without
perfusion of the microdialysis probes, but with blood samples
taken at the appropriate time points.
For the scheduled feeding experiment, rats were entrained to a
scheduled feeding regimen very much similar to our previously
published method [16,41,75]. However, to ensure a more robust
glucose and insulin response (in view of the somewhat more
arousal evoking environment of hypothalamic manipulations), rats
were entrained to four instead of six meals spread equally over the
L/D cycle. In a pilot experiment we assured that this 4-meals-a-
day schedule also evoked a daily rhythm in feeding-induced insulin
responses. Meals started at ZT2, ZT8, ZT14, and ZT20. The
access to food was 15 minutes for the day-time and 12 minutes for
the night-time meals. The rats were given three weeks to adapt to
the feeding schedule.This regular feeding schedule was maintained
until the end of the experiments.
Histology. When the experimental protocol was completed
animals were anaesthetized with CO2/O2 and decapitated. Brains
were subsequently removed, blocked, frozen, sectioned (40 mm)
through the hypothalamus, and stained with cresyl violet. In the
case of SCN-lesions the sections were processed for vasopressin
and VIP immunocytochemistry.
Analytical methods. Blood samples were immediately chilled
on ice in tubes containing a 10 ml solution of 2.5% EDTA+10%
benzamidine hydrochloride (BDH) and centrifuged at 4 C. Plasma
was then stored at 280 C until further analysis. Plasma glucose
concentrations were determined using a Glucose/GOD-Perid
method (Boehringer Mannheim, Mannheim, Germany). Plasma
immunoreactive insulin and corticosterone concentrations were
measured using radioimmunoassay kits (LINCO Research Inc.,
Missouri, USA and ICN Biomedicals, Costa Mesa, CA,
respectively). All samples were assayed in duplicate. Hepatic
glycogen content was measured as described previously [76].
Statistical analysis. We evaluated the kinetics of the plasma
hormone and glucose concentrations as a consequence of the
hypothalamic infusions (and the food intake) by using the increments
of their plasma concentrations compared with the t=0 value. The
significance of the infusion- (or feeding-)induced variations in plasma
glucose and hormone values was assessed using a multivariate
analysis of variance (MANOVA) with repeated measures with
Sampling (6 levels) and Treatment (2 levels, i.e. experimental day versus
control day)asthe repeatedwithin-animalfactorsand,dependingon
the experiment, ZT-time (2 levels) or Lesion (2 levels) as a between-
animalfactor.MANOVA wasfollowed bypost-hoctesting (Fischer’s
least significant difference (L.S.D.)) if significant effects of Treatment,
ZT-time, Food, Lesion, or Interaction were detected. In Experiment-2
(SCN lesions) we also used the area under the curve (AUC) as a
reflection of the overall change in the 180 min (post)infusion period
to evaluate the plasma glucose changes. Also the AUC was
calculated from the incremental data. Within- and between-group
differences in (basal) glucose and hormone concentrations were
analyzed using the Student’s t-test for paired and unpaired samples,
respectively. Statistical significancewas set atp,0.05 fora two-tailed
test.
Supporting Information
Figure S1 Supplemental Fig. 1 Changes in plasma glucose,
glucagon and corticosterone concentrations during a 2-h Bicucul-
line administration in the PVN of ad libitum fed (closed circles),
16-h food-deprived (closed triangles in the left column) or 40-h
food deprived animals (closed triangles in the right column).
Bicuculline was administered from ZT5–ZT7. Open symbols
show the results of the control experiment in the same animals one
week later (i.e. with food-deprivation, but without Bicuculline
administration). In food-deprived animals food was removed at
ZT12 on the day before (,16-h food deprivation) or 2 days before
the Bicuculline experiment (,40-h food deprivation). In ad
libitum fed animals food was only absent during the experiment,
i.e. ZT3–ZT8. For details of statistical analysis see Tables S4 and
S5.
Found at: doi:10.1371/journal.pone.0003194.s001 (8.73 MB TIF)
Figure S2 Supplemental Fig. 2 Changes in plasma corticoste-
rone concentrations during a 2-h administration of Bicuculline in
the PVN of SCN-lesioned (closed triangles) and sham-lesioned
animals (closed circles). Open symbols show the results of the
control experiment in the same animals one week later.
Notwithstanding the profound reduction of the Bicuculline
induced hyperglycemia in the SCN-lesioned animals (Fig. 3) the
corticosterone responses in these animals are still intact. During
the control day the SCN-lesioned animals showed even a
somewhat higher (stress) response (Lesion, p=0.024 and Sam-
ple6Lesion, p=0.007).
Found at: doi:10.1371/journal.pone.0003194.s002 (7.24 MB TIF)
Figure S3 Supplemental Fig. 3 Changes in plasma corticoste-
rone concentrations during a 2-h administration of NMDA, the
NMDA antagonist MK801, Bicuculline, or Muscimol in the PVN
at either ZT5 or ZT15. The results of the ZT5 experiments are
represented by circles and those of the ZT15 experiments by
triangles. Filled symbols indicate the effect of the drug, whereas
open symbols show the results of the control experiment in the
same animals one week later.
Found at: doi:10.1371/journal.pone.0003194.s003 (5.63 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0003194.s004 (0.04 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0003194.s005 (0.08 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0003194.s006 (0.08 MB
DOC)
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